NCT04636086

Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

Vitamin D Supplementation and Covid-19: a Randomised, Double- Blind, Controlled Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: University of Liege · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to evaluate the clinical efficacy and safety of vitamin D supplementation in hospitalized patients with COVID-19.

Detailed description

Phase IV, interventional, randomised, double blind, placebo-controlled and parallel study to evaluate the clinical efficacy and safety of vitamin D supplementation in hospitalized patients with COVID-19. Patients will participate in the study for a maximum of 9 weeks, which includes an up to 6-week treatment period and a maximum of 3-week follow-up period. A total of 100 (50 in each group) patients will be randomized in the study and will either receive the test treatment or the placebo treatment.

Conditions

• Covid19

Interventions

Type	Name	Description
DRUG	Cholecalciferol	Vitamin D supplementation
OTHER	Placebo	Placebo comparator

Timeline

• Start date: 2020-11-12
• Primary completion: 2022-04-10
• Completion: 2022-05-15
• First posted: 2020-11-19
• Last updated: 2022-05-19

Locations

1 site across 1 country: Belgium